Article thumbnail

Components of physical capacity in patients with chronic obstructive pulmonary disease: relationship with phenotypic expression

By Eduardo Márquez-Martín, Pilar Cejudo Ramos, José Luis López-Campos, María del Pilar Serrano Gotarredona, Silvia Navarro Herrero, Rodrigo Tallón Aguilar, Emilia Barrot Cortes and Francisco Ortega Ruiz
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:3048086
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1964). American emphysema and British bronchitis. A standardized comparative study. Am Rev Respir Dis.
  2. American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing.
  3. (2003). Analysis of the factors related to mortality in chronic obstructive pulmonary disease. Role of exercise capacity and health status. Am J Respir Crit Care Med.
  4. (1994). Aprpropriate strength training. Med Clin North Am.
  5. (1983). Are “pink puffers” more breathless than “blue bloaters”? Br Med J.
  6. Association between markers of emphysema and more severe chronic obstructive pulmonary disease.
  7. (2004). ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J.
  8. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease.
  9. (2006). Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med.
  10. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using highresolution computed tomography.
  11. Computed tomographic measurements of airway dimensions and emphysema in smokers.
  12. (1982). Computed tomography in pulmonary emphysema. Clin Radiol.
  13. (2007). Determinants of the physiological systems responses to muscular exercise in helathy subjects. Eur Respir Mon.
  14. Development of a shuttle walking test of disability in patients with chronic airways obstruction.
  15. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.
  16. Evaluation of clinical methods for rating dyspnea.
  17. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation.
  18. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress.
  19. (2006). Global Initiative for Chronic Obstructive Lund Disease (GOLD)
  20. Inflamtory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects.
  21. Inspiratory fraction and exercise impairment
  22. Mid-Arm muscle area is a better predictor of mortality tan body mass index in COPD.
  23. Mortality in COPD: role of comorbidities.
  24. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis.
  25. (1995). Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med.
  26. (1995). Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med.
  27. (1987). Normativa sobre gasometría arterial.
  28. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease.
  29. (1999). Peripheral muscle strength in stable COPD patients: correlation with respiratory function variables and quality of life. Arch Bronconeumol.
  30. (1998). Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med.
  31. Prediction of maximum exercise tolerance in patients with COPD.
  32. Predictors of mortality in patients with emphysema an sevre airflow obstruction.
  33. (1982). Psychophysical bases of perceived exertion. Med Sci Sports Exerc.
  34. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease.
  35. (1997). Radiology of obstructive pulmonary disease.
  36. (1985). Recomendaciones de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Normativa para la espirometría forzada.
  37. Recommendations on the use of exercise testing in clinical practice.
  38. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study.
  39. (1997). Reproducibility of a shuttle walking test in patients with chronic obstructive pulmonary disease. Arch Bronconeumol.
  40. (1959). Respiratory function tests: normal values at median altitudes and the prediction of normal results. Am Rev Tuberc.
  41. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
  42. (1987). Standardization of spirometry –
  43. (2006). Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease. Arch Bronconeumol.
  44. (2003). The assessment of health status among patients with COPD. Eur Respir J Suppl.
  45. The association between small airway obstruction and emphysema phenotypes in COPD.
  46. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
  47. The immune response to resistive breathing.
  48. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
  49. (1995). The Spanish translation and evaluation of a quality-of-life questionnaire in patients with chronic obstructive pulmonary disease. Arch Bronconeumol.